ATC Group: L01CE01 Topotecan

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of L01CE01 in the ATC hierarchy

Level Code Title
1 L Antineoplastic and immunomodulating agents
2 L01 Antineoplastic agents
3 L01C Plant alkaloids and other natural products
4 L01CE Topoisomerase 1 (TOP1) inhibitors
5 L01CE01 Topotecan

Active ingredients in L01CE01

Active Ingredient

Topotecan involves the inhibition of topoisomerase-I, an enzyme intimately involved in DNA replication.

Related product monographs

Document Type Information Source  
 HYCAMTIN Hard capsule MPI, EU: SmPC European Medicines Agency (EU)
 HYCAMTIN Powder for concentrate for solution for infusion MPI, EU: SmPC European Medicines Agency (EU)

United States medicines

Medicines classified under this ATC code globally

Australia (AU)

Austria (AT)

Brazil (BR)

Croatia (HR)

Cyprus (CY)

Estonia (EE)

Finland (FI)

France (FR)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Italy (IT)

Japan (JP)

Lithuania (LT)

Netherlands (NL)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.